Frankfurt - Delayed Quote EUR

Akari Therapeutics, Plc (CLA.F)

1.1200
-0.0400
(-3.45%)
At close: May 9 at 8:08:39 AM GMT+2

Key Executives

Amounts are as of December 31, 2024 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.
NameTitlePayExercisedYear Born
Mr. Abizer Gaslightwala CEO, President & Director 1.6k -- 1974
Dr. Torsten Hombeck Ph.D. Chief Financial Officer 259.07k -- 1970
Dr. Miles Nunn Chief Scientific Officer -- -- 1970
Dr. Satyajit Mitra Ph.D. Executive Director & Head of Oncology -- -- 1975
Mr. Mark F. Kubik M.B.A. Head of Business Development - Oncology -- -- 1965

Akari Therapeutics, Plc

22 Boston Wharf Road
Floor 7
Boston, MA 02210
United States
929 274 7510 https://www.akaritx.com
Sector: 
Healthcare
Industry: 
Biotechnology
Full Time Employees: 
8

Description

Akari Therapeutics, Plc, a clinical-stage biopharmaceutical company, focuses on developing advanced therapies for autoimmune and inflammatory diseases. Its lead product candidate is nomacopan, a second-generation complement inhibitor that prevents inflammatory and prothrombotic activities. The company also develops PASylated-nomacopan, which is in preclinical development for the treatment of geographic atrophy secondary to dry age-related macular degeneration; and hematopoietic stem cell transplant-related thrombotic microangiopathy (HSCT-TMA) combined with nomacopan, which is in phase 3 clinical development for the treatment of pediatric HSCT-TMA. The company is headquartered in Boston, Massachusetts.

Corporate Governance

Akari Therapeutics, Plc’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

May 13, 2025 at 8:00 PM UTC - May 28, 2025 at 8:00 PM UTC

Akari Therapeutics, Plc Earnings Date

Recent Events